MedTrace Logo

Stress Reduction in Ovarian Cancer

NCT01790789 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2019-11-19

No results posted yet for this study

Summary

The purpose of this study is to investigate the effects of a stress reduction program on the quality of life of ovarian cancer patients during primary adjuvant chemotherapy.

Conditions

  • Ovarian, Fallopian, and Primary Peritoneal Cancer

Interventions

BEHAVIORAL

Daily stress reduction program

Subjects will participate in activities of a daily stress reduction program.

OTHER

Attention control

Subjects will receive periodic phone calls to review study protocol and will receive stress reduction program materials at the end of the study.

Sponsors & Collaborators

  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Stephen Rose, MD · University of Wisconsin, Madison

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2016-08-09
Completion
2016-12-06

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01790789 on ClinicalTrials.gov